ADAM12 and rectum adenocarcinoma: Our observation in non-RT patients is supported by data from the Human Protein Atlas (proteinatlas.org), which shows that ADAM12 expression in colon and rectal adenocarcinomas of stages I-III does not correlate with patient survival [41].